Seattle stem cell startup lands $10M to speed development of its drug discovery platforms

The company aims to close the gap between the results of preclinical studies and what actually happens in a clinical setting.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - December 30, 2021 Category: Pharmaceuticals Authors: Paxtyn Merten Source Type: news